
FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms
For Immediate Release: May 22, 2025 The U.S. Food and Drug Administration (FDA)’s Center for Devices and Radiological Health (CDRH) issued General Correspondence Letters to two third-party testing companies in China after discovering data that was …